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Abstract 
Background: De novo production of multi-hydroxylated diterpenoids is challenging due to the lack of efficient 
redox systems.
Results: In this study a new reductase/ferredoxin system from Streptomyces afghaniensis (AfR·Afx) was identified, 
which allowed the Escherichia coli-based production of the trihydroxylated diterpene cyclooctatin, a potent inhibi-
tor of human lysophospholipase. This production system provides a 43-fold increase in cyclooctatin yield (15 mg/L) 
compared to the native producer. AfR·Afx is superior in activating the cylcooctatin-specific class I P450s CotB3/CotB4 
compared to the conventional Pseudomonas putida derived PdR·Pdx model. To enhance the activity of the PdR·Pdx 
system, the molecular basis for these activity differences, was examined by molecular engineering.
Conclusion: We demonstrate that redox system engineering can boost and harmonize the catalytic efficiency of 
class I hydroxylase enzyme cascades. Enhancing CotB3/CotB4 activities also provided for identification of CotB3 
substrate promiscuity and sinularcasbane D production, a functionalized diterpenoid originally isolated from the soft 
coral Sinularia sp.
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Background
Production of functionalized terpenoids in heterologous 
microbial hosts allows sustainable and scalable produc-
tion of bioactive compounds, such as the plant-derived 
tumor therapeutic taxol or artemisinin [1, 2]. Efficient 
generation of structurally complex, olefinic terpene 
macrocycles in heterologous microbial production sys-
tems is feasible due to recent advances in synthetic bio-
technology. By contrast, the identification and catalytic 
reconstitution of highly substrate specific P450s, that 
enable primary regio- and stereoselective hydroxylation 
of structurally complex olefinic macrocycles, a prereq-
uisite to confer bioactivity on a molecular level, remains 
challenging. Consequently, only few examples of single 
hydroxylation reactions have been achieved [3–9].
Native P450s display a high degree of chemo-, regio- 
and stereoselectivity [4]. In contrast to bacterial class I 
and III hydroxylases, eukaryotic class II P450s are mem-
brane associated that are characterized by a low solubility 
when functional reconstitution is carried out in conven-
tional bacterial hosts such as Escherichia coli [10]. More-
over, plant-derived class II P450s often yield complex 
product mixtures [11].
More generally, catalytic efficiency of P450s is highly 
dependent on electrons delivered by suitable redox part-
ner proteins. In class III P450s the redox partner is fused 
to the hydroxylase activity. Application of the non-native 
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class III flavocytochrome (P450BM3) system has allowed 
hydroxylation of various different mono- and sesquiter-
penoids [12]. However, larger terpene olefin macrocycles 
such as diterpenes with an extended degree of chemical 
complexity, are difficult to be further functionalized by 
engineered class III P450s [13].
In contrast to the situation with class III P450s, the inde-
pendent redox partner proteins for most native class I or 
class II P450s have not been identified, which complicate 
their functional reconstitution in heterologous microbial 
hosts. While eukaryotic class II P450s require the presence 
of a cognate diflavin reductase that incorporates FAD and 
FMN cofactors (CPR), prokaryotic class I P450s depend on 
both a reductase and its cognate ferredoxin protein, that 
together orchestrate the electron transfer (ET) processes. 
Particularly in class I P450s, the ET process is coordinated 
through a transient interaction of the respective redox 
partner proteins, which complicates its comprehensive 
investigation [14]. Hence, the molecular recognition and 
structural interaction between redox partners that govern 
the electron transfer process and class I P450 reactivity are 
only poorly understood. Notably, functional reconstitution 
of various class I P450s have been achieved using the well 
characterized Pseudomonas putida reductase·ferredoxin 
model system (PdR·Pdx), whose cognate hydroxylase is 
the monoterpene specific P450cam which catalyze the 
hydroxylation of camphor [15]. Application of the PdR·Pdx 
system subsequently allowed single step oxidation of sub-
strates [15–17]. However, the interplay of the PdR·Pdx 
system with non-native P450s is often insufficient, thereby 
limiting product formation [18]. At present, the inefficient 
functional reconstitution of P450s has hampered a con-
solidated, heterologous bio-manufacturing approach for 
production of bioactive, multi-functionalized diterpenoid 
macrocycles.
Recently, the endogenous pathway for cyclooctatin 
(cyclooctat-9-en-5,7-diol) biosynthesis has been reported 
from Streptomyces melanosporofaciens (Fig. 1a). Cyclooc-
tatin is a potential anti-inflammatory agent that targets 
human lysophospholipase. The sequential cyclooctatin 
biosynthesis cascade, encodes a geranylgeranyl diphos-
phate (GGDP) synthase (CotB1), the diterpene synthase 
CotB2 and the class I P450s CotB3 and CotB4 respec-
tively (Fig.  1a). While the genes for Cotb3 and CotB4 








Fig. 1 Native and heterologous reconstituted cycloocatin biosynthesis with non-native redox partners. a The cyclooctatin biosynthetic pathway 
encodes a GGDP synthase (CotB1), a diterpene cyclase (CotB2) and two P450 type hydroxylases (CotB3, CotB4). The structure alignments of AfR 
(orange) with PdR (blue) (b) and Afx (orange) with Pdx (blue) (c) are shown. Despite the low primary sequence similarities structure alignments of 
PdR with AfR as well as Pdx with Afx have both a root mean square deviation (RMSD) of 0.1 Å over 404 and 106 aligned amino acid residues, respec-
tively. d GC–MS chromatogram of a silylated cellular extract from the cyclooctatin producing E. coli strain harvested after 48 h of growth.  
e Monitored cell density during fermentation is displayed (±dodecane). f Production of cyclooctatin and its biosynthetic intermediates in the dode-
cane organic phase is shown. g, h Monitored product distribution during fermentation in absence of dodecane
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In this study, we describe the efficient heterologous 
reconstitution of the cyclooctatin biosynthesis cluster by 
introduction of a novel, non-native Streptomyces-derived 
redox system. This is the first account for a complete, het-
erologous biosynthesis cascade of a multi-functionalized 
diterpenoid in E. coli. Our microbial production system 
allows for a 43-fold increased cyclooctatin yield com-
pared to the native producer S. melanosporofaciens. We 
report on the molecular mechanisms that confer superior 
activity to our Streptomyces-derived redox system, com-
pared to the PdR·Pdx model system. Enhanced hydroxyla-
tion efficiency can be achieved by either engineering the 
P450 activity or respective redox partner proteins [20, 
21]. For the first time we engineered the Pdx reactivity on 
the basis of a significantly sequence divergent template 
(Afx), which translated into an activity enhancement of 
the CotB3 activity in excess of 100  %. Enhancement of 
CotB3/CotB4 reactivity allowed subsequent examination 
of their substrate promiscuity by introduction of alterna-
tive terpene synthases into our bacterial production sys-
tem. Surprisingly, we could demonstrate that CotB3 can 
be employed to functionalize other diterpene olefins, such 
as (−)-casbene to yield sinularcasbane D, which has previ-
ously been described from the coral Sinularia sp.
Results
Identification of suitable redox partners for cyclooctatin 
biosynthesis
We adopted a multistep computational strategy to iden-
tify CotB3/B4 specific redox partners. The P. putida 
derived model class I redox system comprising the reduc-
tase (PdR) and ferredoxin (Pdx) proteins was utilized 
as a template for a homology-based search covering all 
available Streptomyces genomes [22]. Due to the lack of 
genomic information the native cyclooctatin producer 
S. melanosporofaciens had to be excluded from our bio-
informatics screen. One putative PdR and several hypo-
thetical Pdx homologs with up to 45 % similarity to the 
respective templates clustered specifically within the 
recently shotgun-sequenced genome of Streptomy-
ces afghaniensis. The identified amino acid sequences 
were subjected to secondary structure analysis using 
the HHpred server tool [23]. Homology modelling by 
the HHpred server tool was achieved using the best hits 
upon HMM (Hidden Markov Model)-HMM comparison 
including the redox system of P. putida, the mitochon-
drial adrenodoxin redox system [20] and the terpredoxin 
system from Pseudomonas sp. [24]. Subsequent struc-
tural alignments of the S. afghaniensis-derived reductase 
and ferredoxin counterparts led to the identification of a 
NADH-dependent ferredoxin reductase (afghanoredoxin 
reductase, AfR) and its corresponding 2Fe-2S ferredoxin 
(afghanoredoxin, Afx) (Fig.  1b, c). While the primary 
amino sequences of new AfR (45 %) and Afx (38 %) pro-
teins differed significantly from the P. putida PdR·Pdx 
model, their structures could be fitted to their P. putida 
counterparts. To verify the activity of the new redox sys-
tem, we engineered the entire cyclooctatin biosynthesis 
cluster into a diterpene producing E. coli system.
In vivo reconstitution of cyclooctatin biosynthesis in E. coli
Five day batch, shake flasks (400 mL) cultures did provide 
several milligrams of cyclooctatin and its biosynthetic 
precursors for GC–MS, 1D-/2D-NMR, CD spectroscopic 
and HR-LC/MS spectrometric analyses, which were 
in full accordance with the published stereochemis-
try of the compounds (Additional file  1: Figures S3a–i, 
S9–11) [19, 25]. Interestingly, no product diastereomers 
were detected, which implies that the CotB3 and CotB4 
hydroxylase activities impose absolute product stere-
oselectivity. As our production system provided suffi-
cient material for detailed structural analysis, we applied 
Mosher`s NMR methodology to cyclooctatin and con-
firmed the absolute configuration of the hydroxyl group 
at C-5 as R (Additional file  1: Figures S3j–t, S4) [26]. 
Scaling up the cyclooctatin production to 1 L shake flask 
cultures did not lead to a significant increase in the trihy-
droxylated product and indicated that the product yield is 
dependent on controlled oxygen supply. Subsequent cul-
tivation in a 5 L bioreactor system with controlled oxy-
gen supply, allowed generation of 13.7 g/L dry cell weight 
biomass. Cyclooctatin was the major product, correlated 
with a maximal cyclooctatin yield of 15 mg/L after 48 h 
cultivation in LB medium supplemented with 40 g/L glyc-
erol (Fig. 1e–h). By contrast, the cyclooctatin production 
in native S. melanosporofaciens was 0.35 mg/L [19]. Inter-
estingly, the 72–96  h cultivation period was marked by 
a steadily decreasing cyclooctatin titer, probably caused 
by oxidative product degradation or by air stripping from 
the fermentation medium. To further increase cycloocta-
tin titers we applied organic overlay fermentation, which 
has been reported to increase yields of other oxygenated 
terpenoids [6, 10, 20]. The methodology was evaluated in 
1 L fermentations supplemented with a 20 % (v/w) dode-
cane overlay. Analysis of the organic phase indicated that 
the hydroxylated cyclooctatin precursors cycloocat-9-en-
7-ol (23  mg/L) and cyclooctat-9-en-5,7-diol (4.8  mg/L) 
were the major products. By contrast, only trace amounts 
of cyclooctatin were detected in the organic layer and the 
cell pellet, suggesting that the metabolic precursors rap-
idly transfer from the cell into the organic layer, render-
ing the hydroxylation cascade ineffective.
Redox partner promiscuity of CotB3 and CotB4
While the genus Streptomyces is known to produce sev-
eral diterpenoids, S. afghaniensis has been reported to 
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produce the antibiotic taitomycin, which is a sulfur con-
taining polypeptide with unknown structure [27, 28]. 
Recently, a variety of volatile hydroxylated as well as 
unmodified sesquiterpenoids have been discovered in S. 
afghaniensis [29]. Therefore, AfR and Afx proteins may 
naturally be involved in sesquiterpene functionalization. 
Therefore, the functional interaction with both CotB3 
and CotB4, which are thought to be specific to cyclooc-
tatin biosynthesis is surprising. Nonetheless, examples 
of non-cognate eukaryotic or prokaryotic redox part-
ner proteins that are capable to activate Streptomyces-
derived class I P450s have been reported [30–32]. On 
a molecular level redox partner promiscuity of class I 
P450s is currently thought to be dependent on the amino 
acid decoration of the respective ferredoxin binding site. 
However, our current understanding of class I redox cas-
cades is incomplete as only three class I P450s in complex 
with their respective innate ferredoxins have been struc-
turally characterized [14, 33–35].
Therefore, a general mechanistic understanding with 
respect to partner recognition, ET and possible addi-
tional ferredoxin-mediated effector roles remains to be 
examined. Additionally, the majority of studies examining 
the ET process on a molecular level have been conducted 
with the model P450cam·Pdx system [14]. Specifically, 
Pdx exhibits a unique effector role that induces structural 
changes in P450cam upon binding [36]. While none of 
the reported ferredoxin proteins were able to establish 
P450cam activity [36], it is possible that an endogenous 
yet unreported ferredoxin homolog was able to establish 
the function of the P450cam hydroxylase. By contrast, 
for P450cin, which is responsible for hydroxylation of the 
monoterpene cineole, a redox partner promiscuity was 
reported [36]. In this instance, the combination of Pdx 
and Adr (mitochondrial adrenodoxin) allowed functional 
activation of P450cin, albeit in slow rates [36]. The recent 
crystal structure of the P450cin complex with its innate 
redox partner, a highly unusual FMN-containing flavo-
doxin (Cdx), demonstrated that P450cin does not depend 
on structural changes mediated by its redox partner pro-
tein [35]. Hence P450cin demonstrates a relaxed redox 
partner preference compared to P450cam.
To elucidate the redox partner promiscuity of CotB3 
and CotB4, we tested their activation with the redox 
system from P. putida, as this redox system seems to 
be structurally very similar to the AfR·Afx system. To 
compare the efficiency of the monooxygenases CotB3 
and CotB4 with the redox systems from P. putida and S. 
afghaniensis, whole cell catalysis experiments were car-
ried out. Therefore, E. coli strains harboring the pACYC 
duet vector comprising either CotB3 or CotB4 combined 
with either AfR-Afx or PdR-Pdx gene cassettes were 
introduced. Production of cyclooctat-9-en-5,7-diol or 
cyclooctatin was monitored 48 h after in vitro addition 
of the corresponding metabolic precursors. In contrast 
to the AfR·Afx system the PdR·Pdx redox system was 
not able to generate detectable amounts of cyclooctat-
9-en-5,7-diol with CotB3 (Fig.  2a). Additionally, only 
minor amounts of cyclooctatin with CotB4 could be 
measured (Fig. 2b). Comparative SDS-PAGE analysis of 
whole cell extracts and subsequent peptide mass finger-
printing analysis of CotB3/4 with associated redox com-
plexes showed significant differences in expression levels 
of the two redox systems as well as the P450s (Addi-
tional file  1: Figure S1c, d). Specifically, the application 
of the PdR·Pdx redox system resulted either in a signifi-
cant overrepresentation of CotB3 or CotB4 and Pdx. By 
contrast, when the AfR·Afx redox system was applied 
very low expression levels of CotB3 as well as Afx were 
detected. Notably, CotB4 expression levels remained the 
constant when the AfR·Afx redox system was utilized. 
This cumulative data suggests that there are substantial 
differences between the AfR·Afx and PdR·Pdx systems 
on both transcriptional as well as translational levels, 
which also affect the respective P450 partner proteins. 
Consequently, we applied an in silico-guided mutagene-
sis approach to examine the molecular interaction of the 
AfR·Afx and PdR·Pdx systems with CotB3 and CotB4, 
respectively.
Molecular basis of redox partner promiscuity
Recently, key amino acids that coordinate the hydroxy-
lation reaction in the P450cam·Pdx complex have been 
reported [14, 15, 37]. In this context, the residues Pdx-
D38 and Pdx-W106 regulate binding and the two ET 
processes between Pdx and P450cam. To examine the 
potential differences of interaction sites in the complexes 
and resulting ET routes of the AfR·Afx·CotB3/4 versus 
the PdR·Pdx·CotB3/4 cascades, we applied a comparative 
structural modelling approach using data of the reported 
P450cam·Pdx complex as reference.
To evaluate the sequence similarity between the P450 
type hydroxylases examined in this study we have con-
ducted a joined structural and sequence alignment. The 
primary structural alignment of CotB3 with P450cam 
(PDB-ID: 4JX1) resulted in an RMSD of 0.142 Å over 313 
aligned amino acid residues, having 19 % sequence iden-
tity. The subsequent alignment of CotB4 and P450cam 
provided an RMSD of 0.144  Å over 339 aligned amino 
acid residues with 18  % sequence identity. This data 
shows that despite low amino acid identity, the overall 
structural features between the different hydroxylase sys-
tems was rather similar. Selected second sphere loops of 
CotB3/4 that have no match in the P450cam counterparts 
were not located within the vicinity of the hydroxylase: 
ferredoxin link and therefore have not been considered 
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in our respective structural alignments. The hypothetical 
interaction regions of CotB3/4 with Afx/Pdx are part of 
the matched helical structures (Additional file  1: Figure 
S2b, d).
The resulting models showed excellent stereochemistry 
in comparison to the reference structures determined by 
X-ray crystallography (Additional file  1: Figure S2m–o). 




Fig. 2 Redox partner induced CotB3/CotB4 substrate promiscuity in a designed E.coli production system. a, b Whole cell hydroxylation experi-
ments using E. coli harboring either a CotB3 or b CotB4 combined with different wild type and mutant redox partners. a Cycloocat-9-en-7-ol or b 
cyclooctat-9-en-5,7-diol have been added in vitro. c Biocatalytic pathway from GGPP to (−)−casbene by the casbene synthase for Jatropha curcas 
(CS) and subsequent hydroxylation to sinularcasbane D by CotB3. d Enlargement of the Cotb3·Afx complex depicting essential molecular interac-
tions. Afx (red) contains inorganic Fe2/S2-cluster (green/magenta). CotB3 (blue) contains prosthetic heme group (gray; Fe, magenta) and cyclooct-9-
en-7-ol (red). Hydrogen bonds essential for the successful binding and electron transfer between Afx and CotB3 are shown in black. e Enlargement 
of the CotB3·Pdx complex depicting essential molecular interactions. Pdx (red) contains inorganic Fe2/S2-cluster (green/magenta). CotB3 (blue) 
contains prosthetic heme group (gray; Fe, magenta) and cyclooct-9-en-7-ol (red). Hydrogen bonds essential for the successful binding and electron 
transfer between Afx and CotB3 are shown in black
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involved in the interaction of either CotB3 or CotB4 
with Afx differ significantly from the P450cam·Pdx Ref. 
[14, 38]. Specifically, the models indicate the formation 
of essential hydrogen bonds between CotB3/4-R110/-
R111·Afx-E107, CotB3/4-R113/-R114·Afx-E39 and 
CotB3/4-R114/-R115·Afx-E107 (Fig. 2d; Additional file 1: 
Figure S2i). Structural superposition of CotB3/4·Afx with 
P450cam·Pdx established the structural analogy of Afx-
E39 with Pdx-D38 as well as Afx-E107 with Pdx-W106. 
CotB3/4-R110/-R111·Afx-E107 and CotB3/4-R113/-
R114·Afx-E39 interactions are apparently analogous to 
P450cam-R109·Pdx-W106 and P450cam-R112·Pdx-D38, 
respectively [37]. However, the hydrogen-bond based 
interaction between CotB3/4-R114/-R115 and Afx-E107 
detected in silico, significantly differs from the hydro-
phobic interaction between P450cam-A113 and Pdx-
W106. These amino acids are essential for binding of 
redox partners in P450cam·Pdx and the two ET steps 
[14]. Accordingly, models of CotB3/4·Pdx do not show an 
interaction between R114/R115 and Pdx-W106 (Fig. 2e). 
These findings argued for a polar interaction between 
CotB3/4-R114/-R115 and Afx-E107, presumably par-
ticipating in CotB3/4·Afx binding and the ET processes 
analogous to its P. putida equivalent.
Guided by the Afx residues, we modified either Pdx-
D38 and/or -W106 to verify our modelling approach, 
resulting in a series of Pdx mutants (Pdx-D38E, Pdx-
W106E and Pdx-D38E/W106E). As Afx expression lev-
els were generally very low, in  vitro reconstitution of 
the P450·Afx systems was not possible. Therefore, we 
decided to evaluate our in silico-guided, optimization of 
CotB3/4 activation by the mutant Pdx ferredoxins utiliz-
ing whole cell biocatalysis approach. In our engineered 
diterpene production system we replaced native Pdx by 
respective variant forms and then evaluated the result-
ing alteration in terpene product formation by whole 
cell catalysis. Surprisingly, the Pdx-W106E mutant sig-
nificantly increased cyclooctat-9-en-5,7-diol formation 
compared to the Afx control (Fig.  2a). The Pdx-W106E 
mutant also led to increased cyclooctatin formation, 
indicating a successful interaction with both CotB3 and 
CotB4 (Fig. 2b). Pdx-D38E and Pdx-D38E/W106E, how-
ever, did not allow the production of cyclooctat-9-en-5,7-
diol and did not increase cyclooctatin titers compared to 
the Pdx reference control. Whole cell SDS-PAGE analysis 
of Pdx-D38E and Pdx-D38E/W106E combined with pep-
tide mass fingerprinting of P450-associated protein com-
plexes corroborates these results (Additional file 1: Figure 
S1c, d). Interestingly, the expression levels of Pdx-W106E 
and CotB3 decreases to the level of the CotB3·Afx com-
plex, which was confirmed by multiple repeats and 
resequencing of the constructs. In contrast, expression 
levels of CotB3·Pdx-D38E and CotB3·Pdx-D38E/W106E 
complexes were similar in respect to the expression of 
the wild type CotB3·Pdx complex. For the CotB4·Pdx-
mutant complexes almost no alteration in expression lev-
els could be detected compared to wild type CotB4·Pdx 
complex.
Substrate promiscuity of class I CotB3/4 hydroxylase 
activities
Efficient reactivity of class I P450 hydroxylases strictly 
depends on the use of the suitable redox partner pro-
tein. By contrast, their substrate promiscuity is depend-
ent on the amino acid decoration of hydroxylase active 
site. As CotB3 and CotB4 have not yet been character-
ized with respect to their substrate promiscuity we 
examined the application of CotB3 and CotB4 with 
respect to hydroxylation of alternative diterpene macro-
cycles. Therefore, we exchanged the diterpene synthases 
CotB2 with alternative diterpene synthases in  vitro as 
well as in our heterologous terpene production sys-
tem. Consequently, R-cembrene A [39], (−)−casbene 
[40], (1R,3E,7E,11S,12S)-3,7,18-Dolabellatriene [39] and 
taxa-4,5-11,12-diene [41] were evaluated as alternative 
hydroxylation substrates. Surprisingly, CotB3 was able 
to hydroxylate 20 % of (−)−casbene yielding 1.4 mg/L of 
a single mono-hydroxylated product (Fig.  2c). GC–MS 
and 1D-/2D-NMR analysis, allowed identification of the 
compound as sinularcasbane D (Additional file  1: Fig-
ures S6, S7, S8a–g, S10) [42] This is the first report of a 
recombinant, stereoselective formation of sinularcasbane 
D, which has initially been isolated from the soft coral 
Sinularia sp. [42]. The biological activity of hydroxylated 
casbene diterpenoids has not been extensively explored. 
However some members of this group display moderate 
cytotoxicity and antimicrobial activity [42]. Molecular 
docking of (−)−casbene into the CotB3 active site, estab-
lished the optimal positioning for hydroxylation at C-10 
(Additional file 1: Figure S2k).
Discussion
Identification of the novel AfR·Afx redox system from 
S. afghaniensis, allowed efficient reconstitution of the 
CotB3 and CotB4 hydroxylation activities, which enabled 
the first de novo biosynthesis of the trihydroxylated dit-
erpene cyclooctatin in E. coli. The focus of the current 
study to establish efficient hydroxylation steps of cyclooc-
tatin precursors to enhance the final product titer. To 
our knowledge this is the first example of a consecutive 
P450-mediated hydroxylation cascade described for a 
diterpene macrocycle in E. coli. What is more, our rather 
simple production system provided for a 43-fold increase 
in cyclooctatin yield compared to the native producer 
S. melanosporofaciens. The novel AfR·Afx redox system 
was superior in activating CotB3/CotB4 hydroxylation 
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activities compared to the P. putida-derived PdR·Pdx 
model. Since AfR and Afx proteins show significant pri-
mary sequence divergence compared to their PdR·Pdx 
counterparts, the former may be particularly suitable to 
activate various Streptomyces-derived monooxygenase 
systems.
The molecular basis for this stimulating effect was 
examined by in silico-guided mutagenesis studies. This 
methodology allowed experimental identification of 
Afx residues E39 and E107, which interface with part-
ner amino acids of the respective P450s. In silico-guided 
mutagenesis at the equivalent CotB3/4 binding site of 
Pdx did assume enhanced protein·protein interaction 
and ET capabilities. Therefore, the W to E substitution 
in Pdx-106 presumably translated to enhanced CotB3 
activities in excess of 100 %. As Afx expression levels are 
generally very low, a detailed in  vitro characterization 
was not possible. Therefore, we at least applied whole 
cell biocataylsis experiments together with comparative 
SDS-PAGE analysis to test our in silico-derived hypoth-
esis. Our results clearly indicate that the Pdx-W106E 
substitution is superior in activation of CotB3 compared 
to the Afx and Pdx wild type ferredoxins. An unex-
pected result, however, was the decrease in the expres-
sion level of CotB3 and Pdx-W106E to the expression 
of Afx and CotB3 in the comparative SDS-PAGE analy-
sis. We are not able to explain this fact, but despite the 
lower expression level of Pdx-W106E and CotB3 in this 
specific experiment, the system shows a 100 % increase in 
cyclooctat-9-en-5,7-diol production. Therefore, this the 
first experimental indication of non-cognate redox part-
ner engineering based on the induced fit model reported 
for the Pdx·P450cam interaction [14].
Nonetheless, caution is required in mutating essential 
amino acid residues at the P450 binding site of ferredox-
ins as these residues also play a role in determination 
of the correct binding mode with and participate in ET 
from the NADH-dependent reductase. The surprising 
decrease in productivity of the Pdx-D38E and Pdx-D38E/
W106E constructs might be explained by a reduced inter-
action with PdR. As binding and ET between PdR and 
Pdx rely on a sensitive interaction between PdR-R310 and 
Pdx-D38, the Pdx-D38E substitution apparently leads to 
a significant attenuation of these processes, which is in 
line with previous reports [37]. This, in turn, argues for 
differences in binding and ET processes in the AfR·Afx 
compared to PdR·Pdx complex. A structural superposi-
tion of PdR·Pdx with the modelled AfR·Afx complex 
highlights these differences (Additional file 1: Figure S2j). 
In addition to the identified key residues in Afx, E39 and 
E107 that are presumably important for partner recogni-
tion with and ET to CotB3/4, other residues comprising 
the binding surface between the P450 and Afx have to 
be taken into account to further optimize this system. A 
recent report on P450cam·Pdx interaction demonstrated 
that in addition to essential amino acid residues involved 
in redox partner recognition and ET, other interactions 
contribute to the initial binding of both proteins [43]. 
Therefore, we conclude that the reason for the slightly 
lower increase of product titers in the CotB4·Afx and 
CotB4·Pdx-W106E system compared to the CotB3·Afx 
and CotB3·Pdx-W106E system may be due to differing 
binding modes of CotB3 and CotB4 with Afx, inaccessi-
ble by in silico complex modelling.
Our data indicate that the exchange of Pdx-W106 to an 
amino acid that is capable of binding with CotB3/4 and 
facilitating ET is the molecular basis for the increased 
product formation. Accordingly, adjustments of the 
amino acid D38 in Pdx might also lead to more efficient 
binding to CotB3/4 and higher catalytic yields. However, 
as in such a scenario the interaction of Pdx and PdR is 
disturbed, higher catalytic yields were not observed. An 
alternative scenario to enhance the binding and ET effi-
ciency is to alter the ferredoxin binding site of the respec-
tive P450 [20]. Nonetheless, other native and non-native 
class I P450 systems have to be evaluated to delineate a 
generally applicable approach for the improvement of 
biotechnological processes that are dependent on class I 
redox-couples. However, our current methodology could 
assist in identifying a general solution for the adaptation 
of class I redox systems to any non-native P450.
Conclusions
Identification of the AfR·Afx system was essential to 
reconstitute the cyclooctatin-specific P450s CotB3/
CotB4. Elucidation of the molecular basis for the AfR·Afx 
superior activity allowed adaptation of the PdR·Pdx 
model, which in turn resulted in further enhanced CotB3 
activity. Conventionally, enzymatic catalytic turnover of 
non-native substrates is less efficient compared to the 
native counterpart [43, 44]. Hence, the transformation 
of alternative substrates is commonly associated with 
low yields, which negatively impact respective product 
detection. In this respect efficient ET from the ferredoxin 
partner to the P450 active site can facilitate enhanced 
turnover kinetics and space–time product yields. In turn, 
enhanced formation of alternative products improve 
their analytical detection. We evaluated CotB3/CotB4 
substrate promiscuity by exchanging diterpene synthase 
constructs in our heterologous production system. Sur-
prisingly, CotB3 was able to hydroxylate (−)−casbene, 
which is structurally unrelated to cycloocat-9-en-7-ol, its 
native substrate. CotB3 substrate promiscuity allows for 
an efficient and stereoselective production of sinularcas-
bane D, a functionalized diterpenoid from the soft coral 
Sinularia sp. This data indicates that the P450s CotB3 
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and CotB4 may be valuable protein engineering targets 
to enable single functionalization of other diterpenes. 
Hence CotB3/CotB4 engineering would extend the cur-
rent repertoire of recombinant hydroxylase activities 
available to functionalize terpene olefin macrocycles. 
Moreover, optimizing ETs for other class I hydroxylase 
systems by directed redox partner engineering may allow 
a more comprehensive study towards their substrate 
promiscuity. Further, the entire CotB3·CotB4·AfR·Afx 
cascade may be a valuable system for multi-functionali-
zation of alternative olefinic macrocycles.
Methods
General experimental procedure
Chemicals used in this study were obtained from 
standard sources at the highest purity grade available. 
NMR spectra were recorded in CDCl3 or CD3OD with 
an Avance-III 500  MHz (Bruker) at 300  K. 1H NMR 
chemical shifts are given in ppm relative to CHCl3 
(δ = 7.26 ppm) or CD2HOD (δ = 3.31 ppm) and CD3OH 
(δ = 4.87) (1H NMR). 13C NMR chemical shifts are given 
in ppm relative to CDCl3 at δ =  77.16  ppm or CD3OH 
at δ =  49.00  ppm. The 2D experiments (HSQC, COSY, 
NOESY) were performed using standard Bruker pulse 
sequences and parameters.
GC–MS analysis of diterpene products from ethyl 
acetate extractions was done by a Trace GC Ultra with 
DSQII (Thermo Scientific). Probes were silylated (1  h 
at 70  °C) prior to measurement by 37.5  % (v/v) N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 25  % 
(v/v) chlorotrimethylsilan (TMS-Cl) in pyridine. For 
the GC–MS analysis of dodecane probes, 50  μL of the 
dodecane probe was mixed with 45  μL pyridine, 45  μL 
N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 
10 μL chlorotrimethylsilan (TMS-Cl). Silylation was done 
for 4  h at 70  °C. One microlitre sample was applied by 
TriPlus AS onto a SGE BPX5 column (30 m, I.D 0.25 mm, 
Film 0.25  μm). The initial column temperature started 
at 50  °C and was maintained for 2.5  min. Next, a tem-
perature gradient was applied from 50 to 320 °C (10 °C/
min), followed by 3 min maintenance at 320 °C. MS data 
were recorded at 70  eV (EI), m/z (rel. intensity in %) as 
TIC, total ion current. The recorded m/z range covered 
50–650. Quantification was done by using flame ioniza-
tion detector (FID) using 1 mg/mL α-humulene (Sigma-
Aldrich, Germany) as an internal standard.
To apply the FID signal of α-humulene to the silylated 
diterpene products, correlation factors were calculated 
according to the literature [45]. From the determined 
mass concentrations of the silylated diterpene products 
the mass concentrations of the non-derivate products 
were calculated.
High-resolution mass spectra of diterpenes were deter-
mined with Thermo Fisher Acela HPLC system linked to 
a Thermo Fisher Scientific LTQ Orbitrap XL mass. Elec-
trospray ionization was done in positive ion mode.
MALDI-MS analysis using an Ultraflex I (Bruker 
Daltronics) was applied to identify the recombinant 
expressed proteins in the observed bands on SDS-
PAGE. Bands were excised and digested with trypsin as 
described previously [46]. Prior to MS-analysis, pep-
tides were concentrated and purified using C18 ZipTips 
(Merck Millipore) following the manufacturer’s proto-
col. Data analysis was performed using the MASCOT 
software program (Matrix Science, London, UK) along 
with the National Center for Biotechnology Information 
database.
Circular dichroism (CD) spectroscopy was performed 
using a Chirascan plus spectropolarimeter (Applied Pho-
tophysics). Samples were dissolved in acetonitrile and 
spectra were recorded in quartz cuvettes with 0.1  cm 
path length at 20 °C.
Bacterial strains, genes and vectors
The E. coli strain XL-1 Blue was used for cloning and 
Bl21 (DE3) was used for the diterpene production. All 
strains and plasmids were obtained from Novagen/Merk 
Millipore. Genes were synthesized by Life technologies 
GmbH containing the appropriate restriction sites and 
adjusting codon usage for E. coli.
Plasmids for the cyclooctatin production
The 1-deoxy-d-xylulose 5-phosphate (DXP) pathway was 
housed by the plasmids pCola-Duet-1 and pCDFDuet-1, 
while the cyclooctatin biosynthesis genes were carried by 
the plasmids pET-Duet-1 and pACYC-Duet-1. To over-
express the DXP pathway in E. coli BL21(DE3), genes 
from E. coli of the 1-deoxy-d-xylulose 5-phosphate syn-
thase (dxs) (GenBank: YP_001461602.1), 1-deoxy-d-xy-
lulose 5-phosphate reductoisomerase (dxr) (GenBank: 
NP_414715.1), 2-C-methyl-d-erythriol 4-phosphate cyti-
dyltransferase synthase (ispD) (GenBank: NP_417227.1), 
2-C-methyl-d-erythritol 2,4-cyclodiphosphate synthase 
(ispF) (GenBank: NP_289295.1) and Isopentenyl-diphos-
phate delta isomerase (idi) (GenBank: NP_417365.1) 
were synthesized. IspD/ispF was created as a bi-cistronic 
operon. The synthetic genes were introduced into the 
appropriate plasmids according to Table  1 by standard 
cloning techniques.
To achieve biosynthesis of cyclooctatin the native 
geranylgeranyl diphosphate synthase (crte) (GenBank: 
M90698.1) sequence was amplified from Pantoea agglo-
merans (ATCC 27155) using standard protocols. Prim-
ers used were 5′-AAA CCA TGG CAA TGG CAA CGG 
Page 10 of 15Görner et al. Microb Cell Fact  (2016) 15:86 
TCT GCG CA-3′ and 5′-AAA GAA TTC TTA ACT 
GAC GGC AGC GAG TTT-3′. Genes of cotB2 (Gen-
Bank: BAI44338.1), cotB3 (GenBank: BAI44339.1), cotB4 
(GenBank: BAI44340.1) from Streptomyces melanospor-
ofaciens MI614-43F2 as well as the genes to express the 
reductase (afR) (GenBank: WP_020277402) and ferre-
doxin (adx) (GenBank: WP_020276845) from Strepto-
myces afghaniensis were synthesized. CotB3/B4, afR/afx 
and pdR/pdx from Pseudomonas putida were expressed 
from bi-cistronic operons, introduced, respectively, into 
the appropriate plasmids according to Table 2 by stand-
ard cloning techniques.
To evaluate if the P450 hydroxylases CotB3/4 are capa-
ble to functionalize other diterpene skeletons, the dit-
erpene synthase gene cotB2 in the vector pET-Duet-1 
(Table 2) was exchanged by a series of other genes shown 
on Table 3.
Plasmids to evaluate different redox system variants
The catalytic activities of single CotB3 and CotB4 pro-
teins were evaluated using different redox system vari-
ants. The redox system from S. afghaniensis (afR/afx), 
P. putida (pdR/pdx) and mutant variants of P. putida 
(pdR/pdx) were tested. Consequently, the vector pACYC-
Duet-1 was either carrying CotB3 or CotB4 expressing 
genes in multiple cloning site II as well as the bi-cistronic 
operon of reductase/ferredoxin in multiple cloning site I 
(Table 2). Different variants of the pACYC-Duet-1 vector 
are shown on Table 4.
The CotB3 expressing gene was amplified from the bi-
cistronic operon (cotB3/cotB4) using the primers: 5′-ATT 
ACA TAT GCG TGA ACG TGG T-3′ and 5′-ATA TCT 
CGA GTT AAC GCG GTT CAC AAA CCA T-3′. CotB4 
was amplified from the bi-cistronic operon (cotB3/
cotB4) using the primers: 5′-ATT ACA TAT GAA AGA 
TTT TTT TCG TAT GCG CAC-3′ and 5′-ATA TCT 
CGA GTT AAC GAG GTT CCG-3′. The bi-cistronic 
operons expressing (AfR/Afx)/(PdR/Pdx) and CotB3/
B4 were introduced into the pACYC-Duet-1 according 
by standard cloning techniques. Point mutations in Pdx 
protein from the redox system were introduced by the 
QuikChange site-directed mutagenesis protocol. Prim-
ers for pdxD38E were: 5′-GAT ATT GTT GGT GAA 
TGT GGT GGT AGC G-3′ and 5′-CGC TAC CAC CAC 
ATT CAC CAA CAA TAT C-3′. Primers pdxW106E were: 
5′-GAT GTT CCG GAT CGT CAG GAA TAA GCG 
GCC GCA TAA TG-3′ and 5′-CAT TAT GCG GCC 
GCT TAT TCC TGA CGA TCC GGA ACA TC-3′. The 
different pACYC-Duet-1 (afR/afx or pdR/pdx, cotB3 or 
cotB4) vectors were transformed into Bl21 (DE3) cells.
Production of cyclooctatin
The vectors pCola-Duet-1 (dxr, dxs), pCDF-Duet-1 
(ispD/ispF, idi), pET-Duet-1 (crte, cotB2) and the vec-
tor pACYC-Duet-1 (afR/afx, cotB3/cotB4) were intro-
duced into E. coli Bl21(DE3) by standard transformation 
Table 1 Plasmids used to  construct the overexpressed 
DXP pathway in E. coli Bl21 (DE3)




dxr pCola-Duet-1 I NcoI, EcoRI
dxs pCola-Duet-1 II NdeI, XhoI
ispD/ispF operon pCDF-Duet-1 I NcoI, EcoRI
idi pCDF-Duet-1 II NdeI, XhoI
Table 2 Plasmids used to  construct the cyclooctatin bio-
synthesis in E. coli Bl21(DE3)




crte pET-Duet-1 I NcoI, EcoRI
cotB2 or txs or cs pET-Duet-1 II NdeI, XhoI
afR/afx operon or  
pdR/pdx operon
pACYC-Duet-1 I NcoI, NotI
cotB3/cotB4 operon pACYC-Duet-1 II NdeI, XhoI
Table 3 Plasmids used to evaluate hydroxylation of diter-
penes by CotB3/4
Gene(s) Description Diterpene produced
cs Casbene synthase (−)−Casbene
txs Taxadiene synthase Taxa-4,11-diene
cotB2W288G [13] Cyclooctatin synthase (1R,3E,7E,11S,12S)-3,7,18-
Dolabellatriene
cotB2F107A [13] Cyclooctatin synthase (R)- Cembrene A
Table 4 Plasmids used to  compare the activity of  CotB3 
and  CotB4 hydroxylases with  different redox system vari-
ants










CotB4 PdR/Pdx D38E, W106E
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procedures. Cultivation conditions were based on Boghi-
gian et al. [47].
Shake‑flask production culture of cyclooctatin
For cultivation in shake flasks, cells were grown in 100 or 
400 mL medium containing LB medium (10 g/L tryptone, 
5 g/L yeast extract, and 10 g/L NaCl) supplemented with 
100 mM HEPES (pH 7.6), 40 g/L glycerol, 30 µg/mL kan-
amycin, 50 µg/mL streptomycin, 50 µg/mL carbenicillin, 
34 µg/mL chloramphenicol, 1 mM δ-aminolevulinic acid 
(ALA), 1  mM FeSO4  ×  7H2O, 1  mM isopropyl β-d-1-
thiogalactopyranoside (IPTG) and 40 μL 30 % Antifoam 
(A) in 5 L baffled glass flasks. The culture was inoculated 
at OD600 0.1 from an overnight culture (8  h cultivation 
37 °C supplemented with 30 μg/mL kanamycin 50 μg/mL 
streptomycin, 50  μg/mL carbenicillin, 34  μg/mL chlo-
ramphenicol) and cultivated at 25 °C for 4 days.
Batch bioprocess of cyclooctatin
A 5  L fermentation was performed in a 10  L bioreac-
tor (Biostat C, Braun Melsungen, Germany) using LB 
medium (10 g/L tryptone, 5 g/L yeast extract, and 10 g/L 
NaCl) supplemented with 40 g/L glycerol, 30 μg/mL kan-
amycin, 50 μg/mL streptomycin, 50 μg/mL carbenicillin, 
34 μg/mL chloramphenicol, 1 mM δ-aminolevulinic acid 
(ALA), 1 mM FeSO4 × 7H2O and 1 mM isopropyl β-d-
1-thiogalactopyranoside (IPTG). The pH was controlled 
at 7.6 with 4 M NH4OH and 5 M H3PO4. The bioprocess 
was started by inoculation from an overnight culture (8 h 
cultivation 37  °C supplemented with 50  μg/mL kana-
mycin, 50  μg/mL streptomycin, 50  μg/mL carbenicil-
lin, 34 μg/mL chloramphenicol) at OD600 = 0.1 and run 
for 4  days at 25  °C. Oxygen saturation was constantly 
adjusted to 80  %. To monitor the diterpene production 
200 mL aliquots were taken every 24 h in triplicates. To 
determine the dry cell mass 10 mL aliquots were taken, 
centrifuged and dried. The biomass was determined 
gravimetrically.
Batch bioprocess of cyclooctatin with organic overlay
A 1  L fermentation was performed in three paral-
lel bioreactors (Labfors 5 Lux Stirred Tank, Infors 
HT, Switzerland) using LB medium (10  g/L tryptone, 
5  g/L yeast extract, and 10  g/L NaCl) supplemented 
with 40  g/L glycerol, 30  μg/mL kanamycin, 50  μg/mL 
streptomycin, 50  μg/mL carbenicillin, 34  μg/mL chlo-
ramphenicol, 1  mM δ-aminolevulinic acid (ALA), 
1  mM FeSO4  ×  7H2O and 1  mM isopropyl β-d-1-
thiogalactopyranoside (IPTG). The media were supple-
mented with 20  % (v/v) sterile dodecane. The pH was 
controlled at 7.6 with 4 M NH4OH and 5 M H3PO4. The 
bioprocess was started by inoculation from an overnight 
culture (8 h cultivation 37 °C supplemented with 50 μg/
mL kanamycin, 50  μg/mL streptomycin, 50  μg/mL car-
benicillin, 34  μg/mL chloramphenicol) at OD600  =  0.1 
and run for 4 days at 25 °C. Oxygen was supplied at 0.9 
(vvm) and oxygen saturation was constantly adjusted to 
80 %. To monitor the diterpene production 1 mL aliquots 
were taken every 24  h. To determine the dry cell mass 
2 mL aliquots were taken, centrifuged and dried. The bio-
mass was determined gravimetrically.
Production of sinularcasbane D
The vectors pCola-Duet-1 (dxr, dxs), pCDF-Duet-1 
(ispD/ispF, idi), pET-Duet-1 (crte, cs) and the vector 
pACYC-Duet-1 (afR/afx, cotB3) were introduced into E. 
coli Bl21(DE3) by standard transformation procedures. 
Cultivation conditions were based on Boghigian et  al. 
[47].
Batch bioprocess of sinularcasbane D
For cultivation in shake flasks, cells were grown in 
400 mL medium containing LB medium (10 g/L tryptone, 
5  g/L yeast extract, and 10  g/L NaCl), 40  g/L glycerol, 
30  μg/mL kanamycin, 50  μg/mL streptomycin, 50  μg/
mL carbenicillin, 34  μg/mL chloramphenicol, 1  mM 
δ-aminolevulinic acid (ALA), 1  mM FeSO4  ×  7H2O, 
1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) and 
40 μL 30 % Antifoam (A) in 5 L baffled glass flasks. The 
culture was inoculated at OD600 0.1 from an overnight 
culture (8 h cultivation 37 °C supplemented with 30 μg/
mL kanamycin 50  μg/mL streptomycin, 50  μg/mL car-
benicillin, 34  μg/mL chloramphenicol) and cultivated at 
25 °C for 3 days.
Extraction and isolation of cyclooctatin and its 
biosynthetic precursors
For the diterpene isolation the cells were pelleted 
(15 min, 17,500 g, 4 °C). Cyclooctatin and its biosynthetic 
precursors were extracted from the E. coli cell pellet and 
growth medium supernatant in separate approaches. The 
cell pellet was washed with water and resuspended in 
5 mL water. Next, cells were lysed by sonification using a 
Sonoplus HD2070 (Bandelin Electronic) performing five 
repeats on ice (5  min on and 3  min off at 80  % power) 
followed by a three times extraction with 25  mL ethyl 
acetate. The supernatant containing the growth medium 
was additionally extracted three times by 200  mL ethyl 
acetate. All organic phases were combined. After a dry-
ing step with MgSO4 the solvent was removed under 
vacuum. The crude extract was solved in 1  mL ethyl 
acetate and analysed by GC–MS and -FID. Purification 
of cyclooctat-9-en-7-ol was carried out by flash chro-
matography. An isocratic 70/30 hexane/ethyl acetate 
silica step (Silica gel 40, Sigma-Aldrich,) was followed 
by an isocratic 30/70 water/acetonitrile reversed phase 
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chromatography step on a Polygoprep 60-50, C18 col-
umn (Macherey–Nagel). For purification of cyclooctat-
9-en-5,7-diol by flash chromatography, the hexane/ethyl 
acetate solvent was changed to 50/50 and the water/ace-
tonitrile solvent to 10/90. Cyclooctatin was purified by 
flash chromatography using hexane/ethyl acetate 30/70 
as solvent followed by a 10/90 water acetonitrile reversed 
phase.
Extraction and isolation of (−)−casbene 
and sinularcasbane D
For the (−)−casbene and sinularcasbane D isolation, 
cells were pelleted (15  min, 17,500  g, 4  °C). sinularcas-
bane D and its biosynthetic precursor (−)−casbene were 
extracted from E. coli cells and supernatant, separately. 
Extraction of the diterpenes was analogy to the isolation 
of cyclooctatin and its metabolic precursors. The crude 
extract was solved in 1 mL ethyl acetate and analysed by 
GC–MS and -FID. Purification of (−)−casbene and sinu-
larcasbane D was carried out by flash chromatography. 
An isocratic 90/10 hexane/ethyl acetate chromatography 
on silica (Silica gel 40, Sigma-Aldrich) was applied.
Evaluating CotB3/4 for activity on different diterpene 
skeletons
The vectors pCola-Duet-1 (dxr, dxs), pCDF-Duet-1 
(ispD/ispF, idi), pET-Duet-1 (crte, cs)/pET-Duet-1 (crte, 
txs)/pET-Duet-1 (crte, cotB2W288G)/pET-Duet-1 (crte, cot-
B2F107A) and the vector pACYC-Duet-1 (afR/afx, cotB3)/
pACYC-Duet-1 (afR/afx, cotB4) were introduced into E. 
coli Bl21 (DE3) by standard transformation procedures.
Cultivation was done in 400 mL volumes in shake flask 
culture. Cultivation, isolation and identification of diter-
pene products were analog as described in the batch bio-
process of cyclooctatin.
Preparation and purification of MTPA derivatives
Five milligram purified cyclooctat-9-en-5,7-diol were 
esterified with the R- and S- corresponding Mosher acid 
according to literature [26]. The reaction mixtures were 
purified by flash chromatography using an isocratic 
50/50 hexane/ethyl acetate silica phase column (Silica 
gel 40, Fluka Analytical). Treatment of cyclooctat-9-en-
5,7-diol with (R)- and (S)-MTPA chlorides provides the 
(S)- and (R)-MTPA products, derived from esterification 
of the secondary hydroxyl group at C-5, while leaving the 
ternary hydroxyl group at C-20 unaffected.
In vivo assay for comparison of redox‑systems
The electron transfer of different redox system variants 
was evaluated to promote catalytic efficiency of CotB3 
and CotB4. Therefore Bl21(DE3) cells harboring differ-
ent pACYC-Duet-1 (afR/afx or pdR/pdx, cotB3 or cotB4) 
vectors were used in an in  vivo assay. In this assay the 
P450 and a corresponding redox system were expressed 
in the absence of the DXP pathway. The metabolic pre-
cursor cyclooctat-9-en-7-ol (for CotB3) or cyclooct-9-
en-5,7-diol (for CotB4) was added to the medium and the 
amount of catalytic products cyclooct-9-en-5,7-diol (for 
CotB3) or cyclooctatin (for CotB4) was measured.
From an overnight culture (LB medium, 34  μg/mL 
chloramphenicol) Bl21(DE3) cells harboring different 
pACYC-Duet-1 encoding (afR/afx or pdR/pdx, cotB3 or 
cotB4) vectors were grown in 100 mL baffled shake flask 
cultures at 37 °C using 50 mL LB medium supplemented 
with 34  μg/mL chloramphenicol. Bl21 (DE3) harboring 
the empty pACYC-Duet-1 vector was used as negative 
control. All strains were cultivated five times. After the 
cultures reached the OD600 0.8, 1  mM δ-aminolevulinic 
acid (ALA), 1  mM FeSO4 ×  7H2O and 1  mM isopropyl 
β-d-1-thiogalactopyranoside (IPTG) was added and the 
cultures were incubated at 30 °C for 24 h. For the in vivo 
assay, the cell density of the cultures was adjusted to 
OD600 6 by centrifugation (3000g for 5  min) and re-sus-
pended in the appropriate volume. 10 mL of each culture 
(OD600 = 6) were transferred to 50 mL baffled shake flasks 
and supplemented with 100  μM of cyclooctat-9-en-7-ol 
(CotB3) or cyclooct-9-en-5,7-diol (CotB4). Terpenes were 
added in acetonitrile to a final concentration of 0.1  % 
(v/v). The cultures were sealed by membranes (Greiner 
bio-one breath seal 676051) to avoid evaporation and 
incubated at 30  °C for 2  days. To analyze the whole cell 
proteins 100 μL samples were taken every 6 h. The culture 
samples were centrifuged (10,000g for 5 min), the super-
natant was discarded and the cell pellets were stored at 
−20 °C. The samples were analyzed by a 12 % SDS-Page 
gel according to Laemmli. After cultivation the cultures 
were directly lysed by sonification on a Sonoplus HD2070 
(Bandelin Electronic, Germany) performing five repeats 
on ice (5 min on and 3 min off at 80 % power) and sub-
sequently extracted three times with 25 mL ethyl acetate. 
All organic phases were combined. After a drying step 
with MgSO4 the solvent was removed under vacuum. The 
crude extract was solved in 1 mL ethyl acetate and ana-
lyzed by GC–MS. The GC–MS spectra were normalized 
to the total icon count of α-humulene (Sigma-Aldrich, 
Germany), which was used as an internal standard. Quan-
tification was done by determining the total ion count of 
cyclooctatin and cyclooct-9-en-5,7-diol, respectively.
Bioinformatics
Modelling of CotB3 and CotB4
Homology models were built with Schrödinger’s Prime 
[Prime, version 3.4 (Schrödinger, LLC, New York)] from 
alignments derived from PROMALS3D [48]. For CotB3, 
we applied a chimera model using the crystal structure 
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of Streptomyces coelicolor cytochrome P450 (PDB 3EL3, 
39  % sequence identity) as main template and crys-
tal structure of human cytochrome P450 (PDB 3LD6, 
23 % sequence identity) as template for missing loops at 
positions 194–209 and 250–258. We applied the same 
approach for CotB4, with sequence identities of 39 and 
20 % for templates 3EL3 and 3LD6, respectively. Result-
ing models were subject to protonation state assign-
ment at pH 7.0 using PROPKA and protein relaxation 
using restrained minimization at a convergence factor 
of RMSD  =  0.3  Å for the heavy atoms. The prosthetic 
heme group was kept frozen during this process and the 
formal charge of its iron atom set to +3 (high-spin sex-
ted Fe(III)), as we simulated the enzyme-substrate com-
plex right after the resting state where the substrate has 
replaced the distal water.
Docking of CotB3, CotB4 with its substrates
The ligand structures of cyclooct-9-en-7-ol and cyclooct-
9-en-5,7-diol were built with Schrödinger’s Maestro 
[Maestro version 0.6 (Schrödinger, LLC, New York)]. 
Their conformations and partial charges were taken 
from QM minimization with a dielectric constant of 4.8, 
simulating protein environment. Ligand docking was 
done with Schrödinger’s induced fit docking protocol. 
First, the receptor residues within 5.0 Å of the ligand are 
trimmed, then the ligand flexibly docked into the cavity 
and finally the side chains of residues within 5.0 Å vicin-
ity are sampled and minimized together with the ligand. 
The prothetic heme group was kept frozen throughout 
this process and resulting docking poses were sorted by 
the IFDScore.
Modelling of complexes
Secondary structure analysis and modeling of the ter-
tiary structures of putative reductases and ferredoxins 
from S. afghaniensis whole shotgun-sequences was done 
using the HHpred server tool [23]. Structural alignments 
have been performed using the MUSTANG approach of 
YASARA structure [49]. The model of the AfR·Afx com-
plex has been derived by subsequent alignments of both 
AfR and Afx against the PdR·Pdx (PDB-ID·3LB8) com-
plex. Models of CotB3·/CotB4·Afx complexes have been 
derived by the same approach using the P450cam·Pdx 
complex (PDB-ID·4JX1) as template.
Assigned complexes have subsequently been sub-
jected to 10,000 steps of energy minimization in a TIP3P 
water box at pH 7.0 using the YAMBER03 force field 
of YASARA structure. The force field parameters of 
cyclooct-9-en-7-ol and cyclooct-9-en-5,7-diol, the pros-
thetic heme group and the Fe2/S2-cluster was obtained 
using the AutoSmiles force field parameter assignment 
implemented in YASARA structure [50–52]. During 
energy minimization all residues, heavy atoms, prosthetic 
groups and both substrates were unconstrained, non-
bonded cutoff were set to 7.5 Å and PME method (Par-
ticle-Mesh-Ewald) was used for long-range electrostatic 
forces.
Molecular docking of (−)−casbene and sinularcasbane D 
in the cotB3 active site
Molecular Docking was performed using the AutoDock 
Vina program environment of YASARA structure. Sinu-
larcasbane D was docked into a simulation cell (Size: 
X-size  =  16  Å, Y-size  =  16  Å, Z-size  =  16  Å, angles: 
alpha = 90°, beta = 90°, gamma = 90°) around the follow-
ing four residues Cys87, Arg185, Ala282 and Leu361. 999 
docking runs were performed while all atoms of (−)−
casbene and sinularcasbane D were set as rigid. Cluster 
analysis were performed in the AutoDock Vina program 
environment and characterized by binding energy [kcal/
mol], dissociation constant [pM] and contacting receptor 
residues.
Quality assessments
For quality assessments the following tools were used.
Stereochemical quality assessments: PROCHECK soft-
ware package (Ramachandran plot, g-factor) [53, 54].
Assessment of absolute structural model qualities by 
QMEAN Z-scores [55–58].
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